| 000 | 01220 a2200373 4500 | ||
|---|---|---|---|
| 005 | 20250513134531.0 | ||
| 264 | 0 | _c19980224 | |
| 008 | 199802s 0 0 jpn d | ||
| 022 | _a0385-0684 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aInoue, T | |
| 245 | 0 | 0 |
_a[Clinical evaluation based on cost-effectiveness]. _h[electronic resource] |
| 260 |
_bGan to kagaku ryoho. Cancer & chemotherapy _cJan 1998 |
||
| 300 |
_a13-9 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Clinical Trial, Phase III; Controlled Clinical Trial; English Abstract; Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aBrachytherapy _xeconomics |
| 650 | 0 | 4 | _aCost-Benefit Analysis |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHospital Charges |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aLength of Stay |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aNational Health Programs |
| 650 | 0 | 4 |
_aRadiotherapy _xeconomics |
| 650 | 0 | 4 |
_aRadiotherapy, High-Energy _xeconomics |
| 650 | 0 | 4 | _aSurvival Rate |
| 650 | 0 | 4 |
_aTongue Neoplasms _xeconomics |
| 650 | 0 | 4 |
_aUterine Neoplasms _xeconomics |
| 700 | 1 | _aInoue, T | |
| 773 | 0 |
_tGan to kagaku ryoho. Cancer & chemotherapy _gvol. 25 _gno. 1 _gp. 13-9 |
|
| 999 |
_c9433296 _d9433296 |
||